MedTrace Logo

Evaluation of Colorectal Cancer Screening Strategies in China

NCT05440552 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20000

Last updated 2022-07-01

No results posted yet for this study

Summary

A large-scale randomized controlled trial was conducted to compare different colorectal neoplasms screening strategies in China.

Conditions

  • Colorectal Neoplasms

Interventions

DIAGNOSTIC_TEST

Qualitative Fecal immunochemical test + APCS score

Risk stratification using Qualitative Fecal immunochemical test and APCS score

DIAGNOSTIC_TEST

Quantitative Fecal immunochemical test

Use Quantitative Fecal immunochemical only for risk stratification

Sponsors & Collaborators

  • Shandong University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-31
Primary Completion
2023-09-30
Completion
2023-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05440552 on ClinicalTrials.gov